Daiwa Securities Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-326
Closed -$9K 1313
2024
Q3
$9K Hold
326
﹤0.01% 1136
2024
Q2
$8K Hold
326
﹤0.01% 1175
2024
Q1
$7K Hold
326
﹤0.01% 1187
2023
Q4
$6K Hold
326
﹤0.01% 1195
2023
Q3
$5K Hold
326
﹤0.01% 1160
2023
Q2
$8K Hold
326
﹤0.01% 1149
2023
Q1
$8K Hold
326
﹤0.01% 1124
2022
Q4
$5K Buy
326
+59
+22% +$1.1K ﹤0.01% 1157
2022
Q3
$5K Hold
267
﹤0.01% 1161
2022
Q2
$5K Hold
267
﹤0.01% 1171
2022
Q1
$7K Hold
267
﹤0.01% 1154
2021
Q4
$7K Hold
267
﹤0.01% 1171
2021
Q3
$9K Buy
267
+126
+89% +$4.18K ﹤0.01% 1149
2021
Q2
$4K Hold
141
﹤0.01% 1093
2021
Q1
$4K Hold
141
﹤0.01% 1093
2020
Q4
$3K Sell
141
-279
-66% -$4.5K ﹤0.01% 1092
2020
Q3
$5K Hold
420
﹤0.01% 1093
2020
Q2
$6K Hold
420
﹤0.01% 1100
2020
Q1
$6K Hold
420
﹤0.01% 1093
2019
Q4
$11K Sell
420
-46
-10% -$1.27K ﹤0.01% 1053
2019
Q3
$13K Hold
466
﹤0.01% 1019
2019
Q2
$13K Hold
466
﹤0.01% 1042
2019
Q1
$15K Buy
466
+83
+22% +$2.53K ﹤0.01% 1006
2018
Q4
$11K Hold
383
﹤0.01% 992
2018
Q3
$18K Hold
383
﹤0.01% 1006
2018
Q2
$14K Hold
383
﹤0.01% 1031
2018
Q1
$11K Buy
+383
New +$13K ﹤0.01% 1025
2014
Q2
Sell
-90,000
Closed -$3.08M 918
2014
Q1
$3.08M Buy
+90,000
New +$2.79M 0.02% 195

Other funds holding MYGN

Daiwa Securities Group's MYGN Position: Q4 2024 in Review

Daiwa Securities Group sold out of Myriad Genetics (MYGN) in Q4 2024, closing a stake of 326 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in MYGN in Q1 2014 and held it in 28 quarters. The position peaked at $3.08M in Q1 2014. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2024.

  • Daiwa Securities Group reported no remaining Myriad Genetics position as of Q4 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 326 Myriad Genetics shares in Q4 2024, an estimated $9K.
  • Daiwa Securities Group first reported a position in Myriad Genetics in Q1 2014 and held it in 28 quarters.
  • Daiwa Securities Group's Myriad Genetics position peaked at $3.08M in Q1 2014.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2024.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.